Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Blood Factor Services (RBFS) is a specialized healthcare services company and specialty pharmacy focused on the management and distribution of rare blood clotting factors. The company provides comprehensive support for patients with rare bleeding disorders, including hemophilia and von Willebrand disease, by ensuring reliable access to life-saving factor replacement therapies. RBFS operates as a critical link in the supply chain, offering personalized pharmacy services, clinical monitoring, and insurance navigation to optimize patient outcomes. Their business model emphasizes high-touch patient care and specialized logistics for temperature-sensitive biologics. By focusing exclusively on rare blood disorders, the company maintains deep expertise in the specific therapeutic and regulatory requirements of the hematology market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RBFSC.